80 Participants Needed

Mobile Health Messaging for HIV/AIDS

AB
LM
Overseen ByLunthita M Duthely, Ed.D.
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Miami
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a mobile health messaging system (Mobile Health Messaging application) designed to help women with HIV adhere to their treatment plans. The system sends reminders about appointments, prescriptions, and medication, and addresses challenges such as stigma or mistrust of the medical system. Participants will either receive standard care or additional support through this messaging system and patient navigation. Women who have faced issues like missed appointments or detectable viral loads (amount of HIV in the blood) may be well-suited for the trial. As an unphased trial, this study offers participants the chance to contribute to innovative solutions that could enhance adherence to HIV treatment plans.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on helping you stick to your existing HIV treatment plan.

What prior data suggests that this mobile health messaging application is safe for use in HIV care?

Research has shown that mobile health messages, like those in this study, are generally safe. Studies have found that mobile reminders can help people with HIV adhere better to their treatment plans. For example, one study found that these messages helped patients take their medication on time more often. Another study showed that the messages helped patients keep up with their appointments and prescriptions.

No reports indicate harmful side effects from using mobile health messages. These messages are designed to remind and support, not to act as medication or physical treatment. Participants usually handle them well. If considering joining this trial, there is no evidence suggesting any safety concerns from using the mobile health messaging system itself.12345

Why are researchers excited about this trial?

Researchers are excited about the Mobile Health Messaging treatment for HIV/AIDS because it offers a new way to support patients through digital engagement. Unlike standard treatments that primarily focus on medications like antiretrovirals, this approach uses a mobile health application to deliver psycho-educational messages, providing ongoing support and education right at a patient’s fingertips. This method could improve patient adherence to medication and overall health outcomes by offering personalized, real-time guidance and navigation assistance, making it a unique complement to traditional care.

What evidence suggests that the Mobile Health Messaging application could be effective for HIV care?

Research has shown that mobile health tools, such as text message reminders, can help people with HIV adhere to their antiretroviral therapy (ART) medication schedule. In this trial, participants in the Mobile Health Messaging Arm will receive standard care, patient navigation assistance, and the mobile health intervention, which includes psycho-educational messaging. One study found that SMS reminders improved medication adherence among HIV patients. A review of several studies also found that text messages significantly helped young people with HIV adhere to their ART regimen. Additionally, these mobile health tools can enhance the overall well-being of people living with HIV by addressing challenges like stigma and distrust in medical care, making them a valuable component of HIV treatment.678910

Who Is on the Research Team?

LM

Lunthita M Duthely, Ed.D.

Principal Investigator

University of Miami

Are You a Good Fit for This Trial?

This trial is for women over 18 with HIV who have missed appointments, had a detectable viral load, or haven't taken their meds as prescribed. They must be currently in care or recently back in care and own a working cell phone. It's not for men, those under 18, cognitively impaired individuals unable to consent, or without a cell phone.

Inclusion Criteria

Confirmed HIV diagnosis as per the clinic standard
In the 12 months prior to enrollment: missed one or more visits or viral load detectable (>20 mL) or not taking prescribed HIV anti-retroviral medications
I am a woman aged 18 or older.
See 3 more

Exclusion Criteria

Non-working cell phone
I am unable to make medical decisions for myself due to cognitive impairment.
I am under 18 years old.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive mobile health messaging and patient navigation to improve treatment adherence and address barriers to HIV care

12 months
Ongoing virtual interactions

Follow-up

Participants are monitored for changes in clinic attendance, stigma, medical mistrust, and resilience

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Mobile Health Messaging application
  • Standard of Care Treatment
Trial Overview The study is testing an mHealth system that sends text messages to help women with HIV stick to their treatment plans. The goal is to see if this method helps patients keep up with appointments, refill prescriptions on time, take medication regularly and overcome barriers like stigma.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Health Messaging ArmExperimental Treatment2 Interventions
Group II: Control ArmActive Control1 Intervention
Group III: Focus Group ArmActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Published Research Related to This Trial

Text messaging interventions have been shown to effectively improve adherence to antiretroviral therapy and increase appointment attendance among people living with HIV, based on a systematic review of nine high-quality reviews involving 37 studies across 19 countries.
There are significant knowledge gaps regarding long-term outcomes and patient satisfaction with text messaging interventions, indicating a need for further research to fully understand their impact and potential in managing other chronic diseases.
Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer.Mbuagbaw, L., Mursleen, S., Lytvyn, L., et al.[2022]
A systematic review of ten randomized control trials involving 1621 participants found that mobile text reminders (SMS) significantly improved adherence to antiretroviral therapy (ART) in people living with HIV/AIDS, although some studies were underpowered.
There is currently insufficient evidence to support the effectiveness of SMS interventions in improving physical exercise adherence or quality of life, highlighting a need for more robust studies in these areas.
Effectiveness of mobile text reminder in improving adherence to medication, physical exercise, and quality of life in patients living with HIV: a systematic review.Ibeneme, SC., Ndukwu, SC., Myezwa, H., et al.[2022]
This study aims to evaluate the effectiveness of different reminder methods (text messages, reminder calls, or both) in increasing the use of service referrals among 300 participants from community outreach programs.
The research will help determine how mobile phone-based interventions can enhance community engagement and service utilization, potentially guiding future reminder protocols for similar programs across the country.
A Research Protocol to Test the Effectiveness of Text Messaging and Reminder Calls to Increase Service Use Referrals in a Community Engagement Program.Varma, DS., Hart, M., McIntyre, DS., et al.[2020]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39881127/
Effectiveness of an mHealth Intervention With Short Text ...The objective of this study is to evaluate the effectiveness of a mobile health (mHealth) intervention based on SMS text messages to increase antiretroviral ...
A systematic review and meta-analysis | PLOS OneOur objective was to investigate the effectiveness of mobile phone text message reminders in improving ART adherence for adolescents. Methods.
Effectiveness of mobile text reminder in improving adherence ...Mobile text reminder (SMS) system is considered a viable strategy for targeting/facilitating healthy behavioural change including adherence to prescribed ...
Mobile apps for HIV prevention: how do they contribute to our ...This paper considers the particular strengths and opportunities of mHealth tools to address HIV prevention and provides examples of mHealth approaches.
Examining the influence of mHealth interventions on ...mHealth interventions demonstrate potential in improving QoL for individuals living with HIV and/or hypertension.
Meta-analysis of Mobile Phone Reminders on HIV Patients ...This research aims to systematically review the current clinical evidence of the efficacy of mobile phone reminders on retention to care among HIV patients.
Effectiveness of an mHealth Intervention With Short Text ...The objective of this study is to evaluate the effectiveness of a mobile health (mHealth) intervention based on SMS text messages to increase antiretroviral ...
A Text Messaging–Based Support Intervention to Enhance ...This trial will provide insights into using mobile health to enhance PrEP adherence among pregnant and postpartum mothers.
Effect of mobile health intervention on medication time ...This study aimed to assess the impact of Mobile health (M-health) on medication time adherence among people living with HIV/AIDS (PLWHA).
Effectiveness of mobile text reminder in improving adherence ...Mobile text reminder (SMS) system is considered a viable strategy for targeting/facilitating healthy behavioural change including adherence to prescribed ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security